Data gathered: December 26
AI Stock Analysis - Sanofi (SNY)
Analysis generated July 14, 2024. Powered by Chat GPT.
Sanofi is a global biopharmaceutical company headquartered in Paris, France. Known for its extensive portfolio that includes pharmaceuticals, vaccines, and consumer healthcare products, Sanofi operates in over 100 countries. With a commitment to healthcare innovation, Sanofi invests heavily in research and development to drive growth and maintain its competitive edge in the pharmaceutical industry.
Stock Alerts - Sanofi (SNY)
 |
Sanofi | December 17 Price is up by 5.7% in the last 24h. |
|
Sanofi | December 16 Job postings are down by 20.8% in the last couple of days. |
|
Sanofi | December 10 Web Traffic is down by 37.6% over the last month. |
|
Sanofi | December 2 Job postings are up by 28.4% in the last couple of days. |
Alternative Data for Sanofi
About Sanofi
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare.
| Price | $48.29 |
| Target Price | Sign up |
| Volume | 1,640,000 |
| Market Cap | $121B |
| Year Range | $44.44 - $58.53 |
| Dividend Yield | 4.27% |
| PE Ratio | 25.82 |
| Analyst Rating | 67% buy |
| Industry | Drug Manufacturers |
In the news
 |
Fulcrum Therapeutics Receives Termination Notice from Sanofi Ending Collaboration Agreement for LosmapimodDecember 25 - ETF Daily News |
 |
The Zacks Analyst Blog Highlights ServiceNow, AMD, Sanofi, Team and United-GuardianDecember 23 - Yahoo |
 |
Top Research Reports for ServiceNow, AMD & SanofiDecember 23 - Yahoo |
 |
Why Is Sanofi (SNY) Among the Best European Dividend Stocks To Buy Now?December 23 - Yahoo |
|
Sanofi's 21-Valent Pneumococcal Vaccine Enters Phase IIIDecember 23 - Yahoo |
Press Release: Sanofi initiates phase 3 program for PCV21 and expands collaboration with SK bioscience for next-generation pneumococcal conjugate vaccinesDecember 22 - GlobeNewswire |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 14.2B | 4.09B | 10.1B | 2.82B | 4.25B | 1.570 |
| Q2 '24 | 11.4B | 3.39B | 7.99B | 1.11B | 2.51B | 0.930 |
| Q1 '24 | 11.1B | 3.44B | 7.68B | 1.13B | 2.86B | 0.970 |
| Q4 '23 | 22.9B | 8.2B | 14.7B | -555M | 1.64B | 0.890 |
| Q3 '23 | 12.7B | 3.84B | 8.86B | 2.53B | 3.92B | 2.770 |
Insider Transactions View All
No recorded Insider transactions.
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Johnson & JohnsonJNJ |
$145.85 0% | 48 |
 |
Eli Lilly and CompanyLLY |
$792.8 0% | 61 |
 |
PfizerPFE |
$26.69 0% | 36 |
 |
AstrazenecaAZN |
$66.3 0% | 54 |
 |
AbbVieABBV |
$180 0% | 59 |
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| John James |
Sep 2, 24 | Buy | $1K - $15K |
| Rohit Khanna Democrat |
May 6, 24 | Sell | $1K - $15K |
| Rohit Khanna Democrat |
Nov 8, 23 | Buy | $1K - $15K |
Read more about Sanofi (SNY) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, lobbying cost, business outlook & linkedin employees.
What is the Market Cap of Sanofi?
The Market Cap of Sanofi is $121B.
What is Sanofi's PE Ratio?
As of today, Sanofi's PE (Price to Earnings) ratio is 25.82.
What is the current stock price of Sanofi?
Currently, the price of one share of Sanofi stock is $48.29.
How can I analyze the SNY stock price chart for investment decisions?
The SNY stock price chart above provides a comprehensive visual representation of Sanofi's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Sanofi shares. Our platform offers an up-to-date SNY stock price chart, along with technical data analysis and alternative data insights.
Does SNY offer dividends to its shareholders?
Yes, Sanofi (SNY) offers dividends to its shareholders, with a dividend yield of 4.27%. This dividend yield represents Sanofi's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Sanofi in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.
What are some of the similar stocks of Sanofi?
Some of the similar stocks of Sanofi are Johnson & Johnson, Eli Lilly and Company, Pfizer, Astrazeneca, and AbbVie.
.